Clinical Trial Update: A Study of ADX-102 in Subjects With Allergic Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial of ADX-102 in allergic conjunctivitis completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Conjunctivitis

Drugs mentioned

• ADX-102

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Conjunctivitis, Allergic | Phase 2 | Status: COMPLETED | Results posted: 2023-01-09